Ally Bridge Group (NY) LLC
25 holdingsFiling period: 2026-06-30Current AUM: $81.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DFTX | Definium Therapeutics Inc | 400.0K | $18.8M | $13.3M | 16.32% | -- | 2026-06-30 |
| 2 | ABVX | Abivax SA | 125.0K | $16.7M | $10.7M | 13.14% | +91.3K | 2026-06-30 |
| 3 | NERV | Minerva Neurosciences Inc | 2.18M | $12.1M | $5.3M | 6.46% | +520.3K | 2026-06-30 |
| 4 | PMN | Promis Neurosciences Inc | 620.3K | $8.2M | $2.6M | 3.16% | +206.1K | 2026-06-30 |
| 5 | TRAX | First Tracks Biotherapeutics | 284.3K | $5.7M | $13.6M | 16.69% | -- | 2026-06-30 |
| 6 | AXSM | Axsome Therapeutics Inc | 16.5K | $4.0M | $2.2M | 2.68% | -- | 2026-06-30 |
| 7 | ASMB | Assembly Biosciences Inc | 140.0K | $3.8M | $2.9M | 3.51% | -- | 2026-06-30 |
| 8 | WHWK | Whitehawk Therapeutics Inc | 817.9K | $3.7M | $2.6M | 3.14% | -- | 2026-06-30 |
| 9 | EWTX | Edgewise Therapeutics Inc | 83.3K | $3.4M | $3.8M | 4.60% | -77,700 | 2026-06-30 |
| 10 | CLYM | Climb Bio Inc | 249.2K | $3.2M | $2.6M | 3.14% | -- | 2026-06-30 |
| 11 | KURA | Kura Oncology Inc | 290.0K | $3.2M | $2.1M | 2.58% | -- | 2026-06-30 |
| 12 | CTMX | Cytomx Therapeutics Inc. | 775.0K | $2.9M | $1.7M | 2.08% | -125,000 | 2026-06-30 |
| 13 | AVTX | Avalo Therapeutics Inc | 150.0K | $2.8M | $1.0M | 1.27% | -- | 2026-06-30 |
| 14 | PALI | Palisade Bio Inc | 1.23M | $2.6M | $1.4M | 1.70% | -- | 2026-06-30 |
| 15 | SLDB | Solid Biosciences Inc | 256.0K | $2.6M | $1.7M | 2.07% | -511,015 | 2026-06-30 |
| 16 | ANTX | AN2 Therapeutics Inc | 526.3K | $2.5M | $2.1M | 2.58% | -- | 2026-06-30 |
| 17 | — | Urogen Pharma Ltd | 69.2K | $2.5M | $2.5M | 3.12% | -132,941 | 2026-06-30 |
| 18 | CATX | Perspective Therapeutics Inc | 744.0K | $2.5M | $625K | 0.77% | -182,599 | 2026-06-30 |
| 19 | IDYA | Ideaya Biosciences Inc | 67.5K | $2.5M | $2.1M | 2.58% | -- | 2026-06-30 |
| 20 | IVA | Inventiva SA | 634.8K | $2.4M | $2.4M | 2.96% | -110,500 | 2026-06-30 |
| 21 | ALMS | Alumis Inc | 76.5K | $2.2M | $461K | 0.57% | -90,500 | 2026-06-30 |
| 22 | OVID | Ovid Therapeutics Inc | 624.6K | $1.7M | $1.8M | 2.18% | -2,193,898 | 2026-06-30 |
| 23 | EPRX | Eupraxia Pharmaceuticals Inc | 252.2K | $1.7M | $1.7M | 2.13% | -408,200 | 2026-06-30 |
| 24 | IBIO | Ibio Inc | 390.1K | $682K | $288K | 0.35% | -- | 2026-06-30 |
| 25 | TRAW | Traws Pharma Inc | 786.2K | $663K | $174K | 0.21% | -- | 2026-06-30 |
← Scroll →